due to cheaper more effective vaccine against HiB
HAVANA (Reuters) - Cuban researchers have developed the first synthetic vaccine against a bacteria that causes pneumonia and meningitis, a breakthrough aimed at lowering the cost of immunizing children in poorer countries.
"But what could be more precious for society than to have healthy two-month-old babies," he said.
Havana has invested millions of dollars in the industry since the 1980s, achieving major successes such as the discovery of a recombinant vaccine for meningitis B, which has been used in Latin American countries and was licensed to GlaxoSmithKline for sale in Europe and possibly the United States. It has also developed a hepatitis B vaccine that is exported to more than 30 countries.
Haemophilus influenzae type B is the main cause of almost half of the infections in children under five in the world and kills 500,000 children a year, mostly in developing countries, according to UNICEF (news - web sites).